Home Health Care News May 6, 2019
Current Health — makers of an artificial intelligence-powered wearable remote patient monitoring platform — cleared a major regulatory hurdle last month in securing FDA approval. The U.K.-based technology startup now has its sights set on expanding throughout the U.S. market, largely by helping home health agencies adapt to the Patient-Driven Groupings Model (PDGM) and by aiding health systems in their quest to prevent costly re-hospitalizations.
Founded in 2015 as snap40, Current Health has raised more than $11.7 million overall, with its most recent funding round led by London-based ADV.
The startup received FDA approval for its remote patient monitoring technology on April 24.
“That was a massive step forward,” Current Health CEO and co-founder Christopher...
Today's Sponsors
Today's Sponsor